Niacin and statin treatment did not protect heart
NIH stops clinical trial on combination cholesterol treatment — Lack of efficacy in reducing cardiovascular events prompts decision – The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned.